In summary, these results indicate that ANXA1 can regulate the expression of GOT1, promote the adaptive ability of glutamine metabolism mediated tumor associated oxidative stress, further promote tumor growth, and inhibit ANXA1 combined with glutamine deficiency to inhibit tumor growth. The gene discussed is ANXA1; the disease is neoplasm.